Junten Bio

About:

Junten Bio is a company that offers research and development of cell medicines using regenerative medicine technology.

Website: https://juntenbio.co.jp

Top Investors: DCI Partners, HU Group Central Research Institute, Sosei CVC, BiGEN, Miraca Holdings

Description:

JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.

Total Funding Amount:

1.65B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2018-06-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2019-06-04

IPO Status:

Private

Industries: